Therefore, we evaluated two IL-18 SNPs (rs3882891C/A; NC_000011.10:112144037:C:A and rs1946518A/C; NC_000011.10:112164734:A:C) as candidate biomarkers for susceptibility to dyslipidemia. This evidence concerns the gene IL18 and metabolic syndrome.